Neurocrine Biosciences | سرمایه و ذخایر



Equity Capital And Reserves تغییر دادن تاریخ
AbbVie USD 3.32B 2.71B 2024-12
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
ALKERMES USD 1.51B 46.61M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Cytokinetics USD -135372000 121.46M 2024-12
Dynavax Technologies USD 596.8M 84.63M 2024-12
Exelixis USD 2.24B 31.22M 2025-01
Gilead Sciences USD 19.33B 856M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Prothena USD 486.93M 47.44M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Repligen USD 1.99B 12.76M 2025-03
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Teva Pharmaceutical Industries USD 5.72B 344M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Neurocrine Biosciences سرمایه و ذخایر - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - May 2025.